| Q33851008 | A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases |
| Q48419457 | Astroglial c-Myc overexpression predisposes mice to primary malignant gliomas |
| Q79176341 | Cell Death in MMTV-c-myc Transgenic Mouse Mammary Tumors May Not Be Typical Apoptosis |
| Q28588390 | Characterization of two novel nuclear BTB/POZ domain zinc finger isoforms. Association with differentiation of hippocampal neurons, cerebellar granule cells, and macroglia |
| Q52128603 | Disturbed oligodendrocyte development and recovery from hypomyelination in a c-myc transgenic mouse mutant. |
| Q34183774 | Experimental gerontology in the Nordic countries |
| Q73117135 | Expression of Bax, Bcl-2, and P53 in progressive multifocal leukoencephalopathy |
| Q46054259 | Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes |
| Q36438432 | Expression of green fluorescent protein in oligodendrocytes in a time- and level-controllable fashion with a tetracycline-regulated system |
| Q47789207 | Human and mouse proteomic databases: novel resources in the protein universe. |
| Q73066644 | Oligodendrocyte programmed cell death and central myelination deficiency induced in transgenic mice by synergism between c-Myc and Oct-6 |
| Q48394552 | Proteomic changes associated with degeneration of myelin-forming cells in the central nervous system of c-myc transgenic mice |
| Q24297799 | The life and death of oligodendrocytes in vanishing white matter disease |